CommentaryDrug Development

An End to the Myth: There Is No Drug Development Pipeline

See allHide authors and affiliations

Science Translational Medicine  06 Feb 2013:
Vol. 5, Issue 171, pp. 171cm1
DOI: 10.1126/scitranslmed.3003505

Article Information

vol. 5 no. 171 171cm1

DOI: 
https://doi.org/10.1126/scitranslmed.3003505
PubMed: 
23390245
Published By: 
American Association for the Advancement of Science
Print ISSN: 
1946-6234
Online ISSN: 
1946-6242
History: 
  • .
Copyright & Usage: 
Copyright © 2013, American Association for the Advancement of Science

Author Information

  1. Kristin Baxter1,2,
  2. Elizabeth Horn1,
  3. Neely Gal-Edd1,
  4. Kristi Zonno1,3,
  5. James O’Leary1,
  6. Patrick F. Terry4 and
  7. Sharon F. Terry1,*
  1. ↵*Corresponding author. E-mail: sterry{at}geneticalliance.org
    1. 1Genetic Alliance, Washington, DC 20008, USA.
    2. 2Booz Allen Hamilton, McLean, VA 22102, USA.
    3. 3Myriad Genetics, Salt Lake City, UT 84108, USA.
    4. 4PXE International, Washington, DC 20008, USA.

    Altmetric

    Article usage

    Article usage: March 2013 to July 2021

    AbstractFullPdf
    Feb 20136846898866
    Mar 201376487121
    Apr 20134593860
    May 20134472738
    Jun 20134433339
    Jul 20132532626
    Aug 20132552232
    Sep 20131404133
    Oct 20131793353
    Nov 201314637100
    Dec 2013873791
    Jan 20141294037
    Feb 20141223865
    Mar 20141373337
    Apr 20141153340
    May 20141062834
    Jun 2014854126
    Jul 2014984929
    Aug 2014864033
    Sep 2014792718
    Oct 2014672418
    Nov 2014472016
    Dec 2014642839
    Jan 2015913854
    Feb 2015442516
    Mar 2015734121
    Apr 2015855029
    May 2015612714
    Jun 2015803123
    Jul 2015662218
    Aug 2015792114
    Sep 20151502221
    Oct 2015846537
    Nov 2015512021
    Dec 2015692417
    Jan 2016491424
    Feb 2016711818
    Mar 2016532611
    Apr 2016501735
    May 2016603628
    Jun 2016553331
    Jul 2016652028
    Aug 2016681518
    Sep 2016571419
    Oct 201670622
    Nov 201655420
    Dec 2016631184
    Jan 2017501527
    Feb 2017501819
    Mar 2017311114
    Apr 2017311734
    May 201741105
    Jun 201724510
    Jul 2017371420
    Aug 2017581117
    Sep 2017532226
    Oct 2017381854
    Nov 2017382028
    Dec 2017641664
    Jan 2018692679
    Feb 2018552537
    Mar 2018501514
    Apr 2018652514
    May 2018684030
    Jun 2018844646
    Jul 2018542926
    Aug 2018610668
    Sep 2018118535
    Oct 2018319045
    Nov 2018327046
    Dec 2018315519
    Jan 2019520243
    Feb 20191521546
    Mar 2019813249
    Apr 201989612
    May 201988321
    Jun 201958618
    Jul 2019148131
    Aug 2019127223
    Sep 201956382
    Oct 201974033
    Nov 201974010
    Dec 201962916
    Jan 2020910831
    Feb 20207418
    Mar 20204509
    Apr 202065915
    May 20204435
    Jun 2020164720
    Jul 202022418
    Aug 2020313722
    Sep 202013220
    Oct 2020228546
    Nov 2020174018
    Dec 2020153323
    Jan 202188918
    Feb 202163218
    Mar 2021105339
    Apr 2021295314
    May 202140399
    Jun 202177412
    Jul 2021152317

    View Full Text

    Article Tools

    • Email
    • Download Powerpoint
    • Print

    • Alerts
    • Citation tools

    • An End to the Myth: There Is No Drug Development Pipeline

      By Kristin Baxter, Elizabeth Horn, Neely Gal-Edd, Kristi Zonno, James O’Leary, Patrick F. Terry, Sharon F. Terry

      Science Translational Medicine : 171cm1

      A new map is presented for creating an open, collaborative, and coordinated system for drug development.

      CiteULike logo Connotea logo del.icio.us logo Digg logo Facebook logo Google logo Mendeley logo Reddit logo Twitter logo

    My saved folders

    Stay Connected to Science Translational Medicine

    Related Content

    Similar Articles in:

    Citing Articles in:

    Navigate This Article